The Global Percutaneous Nephrolithotomy Market was valued at USD 1.2 billion in 2024 and is estimated to grow at a CAGR of 6.8% to reach USD 2.3 billion by 2034.
Market expansion is driven by the increasing prevalence of kidney stones, growing patient preference for minimally invasive surgical procedures, rapid technological advancements in PCNL devices, and rising healthcare spending with improved access to specialized care. Minimally invasive PCNL procedures are becoming a preferred solution for treating large or complex kidney stones that cannot be addressed by non-invasive or less invasive techniques. The procedure involves a small incision to access the kidney directly using a nephroscope, allowing precise stone fragmentation and removal with minimal tissue damage and reduced recovery time. Expanding surgical infrastructure in developing regions and government initiatives to improve urological care further boost procedure volumes and broaden patient access to advanced PCNL treatment options.
The nephroscopes segment captured a share of 37.8% in 2024 owing to their indispensable role in PCNL procedures. Rising adoption of miniaturized and digital nephroscopes, along with ongoing product innovations enhancing visualization and surgical precision, reinforces the segment’s leadership. The growing incidence of urolithiasis, influenced by lifestyle factors such as obesity, dehydration, and high-sodium diets, increases the number of patients requiring PCNL procedures, directly driving demand for high-performance nephroscopes.
The standard PCNL segment generated USD 690.4 million in 2024 and is expected to grow at a CAGR of 6.7% through 2034. Standard PCNL continues to be the preferred technique for removing kidney stones larger than 2 cm, including staghorn stones, due to its superior stone clearance rates compared to other treatment options. Its established clinical effectiveness ensures continued adoption across both developed and emerging markets.
North America Percutaneous Nephrolithotomy Market held a 39.8% share in 2024. The region experiences one of the highest incidences of kidney stones globally, driven by factors such as obesity, high sodium intake, sedentary lifestyles, and diets rich in processed foods and animal protein. These factors contribute to increasing demand for PCNL procedures, supporting strong market growth.
Key players in the Global Percutaneous Nephrolithotomy Market include ADVIN, B. BRAUN, Becton, Dickinson and Company, Boston Scientific, Coloplast, COOK MEDICAL, Dornier MedTech, ELMED, EMS ELECTRO MEDICAL SYSTEMS, KARL STORZ, OLYMPUS, PolyDiagnost, Richard Wolf, and Teleflex. Companies in the Percutaneous Nephrolithotomy Market are strengthening their presence through several strategic approaches. They are investing heavily in research and development to enhance device efficiency, miniaturization, and imaging capabilities. Firms are entering partnerships and collaborations to expand geographic reach and diversify product offerings. Strategic acquisitions allow companies to consolidate market share and acquire innovative technologies. Focused entry into emerging markets captures new growth opportunities. Emphasis on advanced digital and minimally invasive solutions enhances competitive positioning.
This product will be delivered within 2-4 business days.
Market expansion is driven by the increasing prevalence of kidney stones, growing patient preference for minimally invasive surgical procedures, rapid technological advancements in PCNL devices, and rising healthcare spending with improved access to specialized care. Minimally invasive PCNL procedures are becoming a preferred solution for treating large or complex kidney stones that cannot be addressed by non-invasive or less invasive techniques. The procedure involves a small incision to access the kidney directly using a nephroscope, allowing precise stone fragmentation and removal with minimal tissue damage and reduced recovery time. Expanding surgical infrastructure in developing regions and government initiatives to improve urological care further boost procedure volumes and broaden patient access to advanced PCNL treatment options.
The nephroscopes segment captured a share of 37.8% in 2024 owing to their indispensable role in PCNL procedures. Rising adoption of miniaturized and digital nephroscopes, along with ongoing product innovations enhancing visualization and surgical precision, reinforces the segment’s leadership. The growing incidence of urolithiasis, influenced by lifestyle factors such as obesity, dehydration, and high-sodium diets, increases the number of patients requiring PCNL procedures, directly driving demand for high-performance nephroscopes.
The standard PCNL segment generated USD 690.4 million in 2024 and is expected to grow at a CAGR of 6.7% through 2034. Standard PCNL continues to be the preferred technique for removing kidney stones larger than 2 cm, including staghorn stones, due to its superior stone clearance rates compared to other treatment options. Its established clinical effectiveness ensures continued adoption across both developed and emerging markets.
North America Percutaneous Nephrolithotomy Market held a 39.8% share in 2024. The region experiences one of the highest incidences of kidney stones globally, driven by factors such as obesity, high sodium intake, sedentary lifestyles, and diets rich in processed foods and animal protein. These factors contribute to increasing demand for PCNL procedures, supporting strong market growth.
Key players in the Global Percutaneous Nephrolithotomy Market include ADVIN, B. BRAUN, Becton, Dickinson and Company, Boston Scientific, Coloplast, COOK MEDICAL, Dornier MedTech, ELMED, EMS ELECTRO MEDICAL SYSTEMS, KARL STORZ, OLYMPUS, PolyDiagnost, Richard Wolf, and Teleflex. Companies in the Percutaneous Nephrolithotomy Market are strengthening their presence through several strategic approaches. They are investing heavily in research and development to enhance device efficiency, miniaturization, and imaging capabilities. Firms are entering partnerships and collaborations to expand geographic reach and diversify product offerings. Strategic acquisitions allow companies to consolidate market share and acquire innovative technologies. Focused entry into emerging markets captures new growth opportunities. Emphasis on advanced digital and minimally invasive solutions enhances competitive positioning.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Procedure Type, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Patient, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies featured in this Percutaneous Nephrolithotomy market report include:- ADVIN
- B. BRAUN
- Becton, Dickinson and Company
- Boston Scientific
- Coloplast
- COOK MEDICAL
- Dornier MedTech
- ELMED
- EMS ELECTRO MEDICAL SYSTEMS
- KARL STORZ
- OLYMPUS
- PolyDiagnost
- Richard Wolf
- Teleflex
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | November 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 1.2 Billion |
| Forecasted Market Value ( USD | $ 2.3 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
